| Code | CSB-MP005998HU1d7 |
| Abbreviation | Recombinant Human CRTAM protein, partial (Active) |
| MSDS | |
| Size | $9.9 |
| Promotion | |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CRTAM mediates adhesion and cytotoxic effector functions in NK and CD8+ T cells through its interaction with CADM1, making quantitative characterization of this receptor-ligand pair essential for understanding immune synapse formation and T-cell activation. This mammalian-expressed construct spanning residues 18–287 demonstrates robust binding to human CADM1 with an EC50 of 2.277–2.649 ng/mL in functional ELISA, providing a validated reagent for ligand-binding assays, competitive inhibition studies, and therapeutic antibody epitope mapping targeting the CRTAM–CADM1 axis. The low picomolar EC50 supports use in surface plasmon resonance and biolayer interferometry experiments requiring sensitive affinity characterization, as well as in screening campaigns for biologics or small molecules that modulate this costimulatory pathway. Purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg align with standards expected in functional binding assays and antibody validation workflows where contaminant interference must be minimized.
There are currently no reviews for this product.